<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.2-a.5'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//medicinacardiometabolica.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://medicinacardiometabolica.com/2026/09/06/diferencia-presion-entre-brazos-significa/</loc>
  <lastmod>2026-09-06T22:17:27Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Diferencia de presión entre brazos: qué significa</news:title>
   <news:publication_date>2026-09-06T22:17:27Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/09/06/eeuu-249-acido-ursodesoxicolico/</loc>
  <lastmod>2026-09-06T16:17:16Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Ácido ursodesoxicólico (Actigall, Urso): para qué sirve, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-09-06T16:17:16Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/09/06/retatrutida-radar-cardiometabolico/</loc>
  <lastmod>2026-09-06T11:42:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Retatrutida y amicretina: Radar cardiometabólico 6 sep</news:title>
   <news:publication_date>2026-09-06T11:42:38Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/09/06/inteligencia-artificial-cardiologia-2026-esc-ensayos-munich/</loc>
  <lastmod>2026-09-06T11:19:02Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Inteligencia artificial en cardiología 2026 ESC: qué ensayos de Múnich ya cambian la consulta y cuáles no</news:title>
   <news:publication_date>2026-09-06T11:19:02Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/09/05/indice-tobillo-brazo-tecnica-e/</loc>
  <lastmod>2026-09-05T22:12:24Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Índice tobillo-brazo: técnica e interpretación</news:title>
   <news:publication_date>2026-09-05T22:12:24Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/09/05/eeuu-248-fluoxetina-vs-sertralina/</loc>
  <lastmod>2026-09-05T16:18:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Fluoxetina vs sertralina: cuál es mejor, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-09-05T16:18:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/09/05/podcast-semanal-pulsos-esc-munich-farmacos-2026-09-05/</loc>
  <lastmod>2026-09-05T11:32:41Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Podcast semanal: semiología del pulso, ESC 2026 de Múnich y fármacos de guardia</news:title>
   <news:publication_date>2026-09-05T11:32:41Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/09/05/sindrome-coronario-agudo-2026-esc-antiagregacion-premium-switch-swedeheart-a-close/</loc>
  <lastmod>2026-09-05T11:13:41Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Síndrome coronario agudo 2026 ESC: no hubo guía nueva en Múnich y qué cambia en antiagregación tras PREMIUM, SWITCH SWEDEHEART y A-CLOSE</news:title>
   <news:publication_date>2026-09-05T11:13:41Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
